Business
Apellis Pharmaceuticals, a Biotech Firm Focused on Rare Diseases and Ophthalmology, is ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Apellis Pharmaceuticals, a biotech firm focused on rare diseases and ophthalmology, is drawing takeover interest from larger drugmakers ...'
Apellis Pharmaceuticals, a biotech firm focused on rare diseases and ophthalmology, is drawing takeover interest from larger drugmakers https://t.co/CSEMvV4Vcj— Bloomberg (@business) April 3, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Apr 03, 2023 07:11 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
